1. |
Sato E, Koyama S, Okubo Y, et al. Acetylcholine stimulates alveolar macrophages to release inflammatory cell chemotactic activity. Am J Physiol, 1998 , 274 : L970 -L979.
|
2. |
Tashkin DP, Celli B, Senn S, et al. A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease. N Engl J Med, 2008 , 359 :1543-1554.
|
3. |
王長征. 藥物治療能改變慢性阻塞性肺疾病患者肺功能的下降速率嗎? 中國呼吸與危重監護雜志, 2009, 8: 1-2.
|
4. |
Saito Y, Azuma A, Morimoto T, et al. Tiotropium ameliorates symptoms in patients with chronic airway mucus hypersecretion which is resistant to Macrolide therapy. Intern Med,2008, 47: 585-591.
|
5. |
張弛, 林如平, 劉洪, 等. 魚腥草注射液對慢性阻塞性肺疾病患者炎癥細胞因子與肺功能影響. 中國中醫藥科技, 2006, 13: 294-295.
|
6. |
Profita M, Bonanno A, Siena L, et al. Acetylcholine mediates the release of IL-8 in human bronchial cells by a NFκB/ ERKdependent mechanism. Eur J Pharmacol, 2008, 582: 145-153.
|
7. |
Bühling F, Lieder N, Kuhlmann UC, et al Tiotropium suppresses acetylcholine-induced release of chemotactic mediators in vitro.Respir Med, 2007, 101: 2386-2394.
|
8. |
宋一平, 崔德健, 茅培英, 等. 慢性阻塞性肺疾病大鼠模型氣道重塑及生長因子的研究. 中華結核和呼吸雜志, 2001, 24: 283-287.
|
9. |
Gosens R, Bos IS, Zaagsma J, et al. Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling. Am J Respir Crit Care Med, 2005, 171: 1096-1102.
|
10. |
張永, 程德云, 王慧, 等. 慢性阻塞性肺疾病大鼠肺內白細胞介素-8 和腫瘤壞死因子-α與氣道炎癥的關系研究. 中國呼吸與危重監護雜志, 2003, 2: 553-558.
|
11. |
謝靜. 重癥急性呼吸綜合征患者血漿細胞因子水平的動態改變. 中華內科雜志, 2003, 42: 643-645.
|
12. |
Keatings VM, Collins PD, Scott DM, etal. Differences ininterleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med, 1996, 153: 530-534.
|
13. |
Crooks SW, Bayley DL, Hill SL, et al. Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: the role of leukotriene B4. Eur Respir J, 2000, 15: 274-280.
|
14. |
Hill AT, Bayley D, Stockley RA. The interrelationship of sputum inflammatory markers in patients with chronic bronchitis. Am J Respir Crit Care Med, 1999, 160: 893-898.
|
15. |
Turner CR, Breslow R, Conklyn MJ, et al. In vitro and in vivo effects of leukotrien B4 antagonism in a primate model of asthma. J Clin Invest, 1996, 97: 381-387.
|
16. |
Profita M, Giorgi RD, Sala A, et al. Muscarinic receptors, leukotriene B4 production and neutrophilic inflammation in COPD patients.Allergy, 2005, 60: 1361-1369.
|
17. |
Jiménez E, Montiel M. Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells. J Cell Physiol, 2005, 204: 678-686.。.
|